FIELD: medicine.
SUBSTANCE: invention refers to biotechnology, and represents a polyclonal Nogo antibody. Also, there are presented a pharmaceutical composition and application of the antibody for preparing a drug.
EFFECT: invention can effectively used for treating central nervous system disorders.
6 cl, 79 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVED NOGO-A-BINDING MOLECULES AND PHARMACEUTICAL APPLICATION THEREOF | 2008 |
|
RU2513697C2 |
| METHODS FOR MAKING POLYCLONAL ANTIBODIES, ANTISERUM CONTAINING POLYCLONAL ANTIBODIES, AND METHODS FOR IMMUNISATION | 1999 |
|
RU2358982C2 |
| ANTI-Nogo ANTIBODIES ("11C7") AND THEIR APPLICATION IN PHARMACEUTICS | 2003 |
|
RU2350623C2 |
| LOCAL APPLICATION OF HSV ANTIBODY | 2015 |
|
RU2703903C2 |
| ANTIBODIES | 2005 |
|
RU2482131C2 |
| NOVEL ANTIBODIES | 2008 |
|
RU2490277C2 |
| APPLICATION OF ANTI-CD40-ANTIBODIES | 2006 |
|
RU2442606C2 |
| ANTIBODY, WHICH RECOGNIZES PEPTIDE T14 ACHE | 2016 |
|
RU2729491C2 |
| ANTIBODIES AGAINST PD-1 AND THEIR USE | 2018 |
|
RU2788616C2 |
| ANTI-EphB4 ANTIBODIES AND METHODS OF USING SAID ANTIBODIES | 2007 |
|
RU2450020C2 |
